hit counter

dementia

Latest Treatments for Frontotemporal Dementia (FTD): High-Dose Oxytocin Emerges as the Standout (2023 Review)

by

Frontotemporal dementia (FTD) is a challenging and impactful neurodegenerative disease. Recent research offers new insights into its management, particularly regarding the effectiveness of pharmacological treatments. Highlights: High-Dose Oxytocin Shows Promise: High-dose oxytocin (72 international units) has been linked to significant improvements in neuropsychiatric symptoms and daily interactive activities in FTD patients. Piracetam Poses Risks: Contrarily, …

Read more

Antidepressants & Dementia Risk in Elderly Users: SSRIs vs. TCAs (2024 Study)

by

Recent research has uncovered connections between the use of antidepressants and the risk of developing dementia in the elderly. This complex relationship, marked by varying results and considerations, is becoming a critical area of study in geriatric medicine and mental health. In light of these findings, it is crucial to delve into the nuances of …

Read more

Caffeine to Prevent Alzheimer’s Disease via Adenosine A2A Receptors? (2023 Review)

by

Alzheimer’s Disease (AD), a prevalent form of dementia, poses significant challenges for individuals and healthcare systems worldwide. Current treatments primarily offer symptomatic relief without altering the disease’s progression. However, emerging research suggests that caffeine, a widely consumed psychoactive substance, may have neuroprotective properties against AD. Highlights: Alzheimer’s Disease is the most common form of dementia, …

Read more

Marijuana Abuse & Early-Onset Frontotemporal Dementia: 34-Year-Old Male (Case Report)

by

A 34-year-old man developed symptoms of frontotemporal dementia (FTD), a rare form of early-onset dementia, after using cannabis for two years. This case highlights the potential risks of long-term cannabis use on brain health, especially for vulnerable individuals. Key Facts: The 34-year-old man used cannabis for two years before experiencing personality changes and behavioral symptoms …

Read more

Gene Editing (CRISPR) for Alzheimers Disease Treatment

by

Alzheimer’s disease (AD) is an incurable neurodegenerative disease and the most common form of dementia. Research is ongoing to better understand AD pathogenesis and explore potential treatments. Genome editing tools like CRISPR/Cas9 offer new approaches to study and potentially treat AD. Key Facts: AD pathogenesis likely involves multiple genetic and environmental factors Gene mutations linked …

Read more

L-Tyrosine Benefits & Unestablished Claims (Scientific Research)

by

Tyrosine is a nonessential amino acid that was discovered circa 1846.  The word “tyrosine” is derived from the Greek word “tyros” which translates roughly to “cheese.” Tyrosine is most commonly cited as “L-tyrosine” or the levorotatory “L” enantiomer due to the fact that L-amino acids are manufactured in cells and used in protein synthesis; dextrorotatory …

Read more